|
Valoración DCF de HCW Biologics Inc. (HCWB)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
HCW Biologics Inc. (HCWB) Bundle
¡Simplifique la valoración de HCW Biologics Inc. (HCWB) con esta calculadora DCF personalizable! Con Real HCW Biologics Inc. (HCWB) financieras y entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de HCW Biologics Inc. (HCWB) en minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | 4.1 | .0 | 6.7 | 2.8 | 1.7 | 1.0 | .6 | .4 | .2 |
| Revenue Growth, % | 0 | 0 | -100 | 0 | -57.72 | -39.43 | -39.43 | -39.43 | -39.43 | -39.43 |
| EBITDA | -6.9 | -5.3 | -12.8 | -14.2 | -23.6 | -.3 | -.2 | -.1 | -.1 | .0 |
| EBITDA, % | 100 | -128.1 | 100 | -211.01 | -829.62 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | .4 | .6 | .5 | .6 | 1.1 | .9 | .5 | .3 | .2 | .1 |
| Depreciation, % | 100 | 13.97 | 100 | 8.77 | 39.95 | 52.54 | 52.54 | 52.54 | 52.54 | 52.54 |
| EBIT | -7.4 | -5.8 | -13.4 | -14.8 | -24.7 | -.3 | -.2 | -.1 | -.1 | .0 |
| EBIT, % | 100 | -142.07 | 100 | -219.78 | -869.56 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | 7.4 | 8.5 | 36.7 | 32.1 | 3.6 | 1.7 | 1.0 | .6 | .4 | .2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | 2.5 | .1 | .4 | 1.5 | 1.1 | .7 | .4 | .2 | .1 |
| Account Receivables, % | 100 | 60.98 | 100 | 6.21 | 54.04 | 64.25 | 64.25 | 64.25 | 64.25 | 64.25 |
| Inventories | .0 | .5 | 2.2 | 1.4 | .0 | .8 | .5 | .3 | .2 | .1 |
| Inventories, % | 100 | 13.13 | 100 | 20.75 | 0 | 46.78 | 46.78 | 46.78 | 46.78 | 46.78 |
| Accounts Payable | .4 | .2 | .2 | 1.2 | 6.2 | 1.1 | .7 | .4 | .2 | .1 |
| Accounts Payable, % | 100 | 3.79 | 100 | 18.24 | 217.02 | 64.41 | 64.41 | 64.41 | 64.41 | 64.41 |
| Capital Expenditure | -1.5 | -.2 | .0 | -10.3 | -6.2 | -.7 | -.4 | -.3 | -.2 | -.1 |
| Capital Expenditure, % | 100 | -4.55 | 100 | -152.86 | -218.26 | -40.91 | -40.91 | -40.91 | -40.91 | -40.91 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -7.3 | -5.8 | -12.8 | -14.6 | -24.7 | -.3 | -.2 | -.1 | -.1 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -7.9 | -8.7 | -11.6 | -22.8 | -24.6 | -5.6 | .2 | .1 | .1 | .1 |
| WACC, % | 7.24 | 7.25 | 7.2 | 7.24 | 7.25 | 7.23 | 7.23 | 7.23 | 7.23 | 7.23 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 1 | |||||||||
| Present Terminal Value | 1 | |||||||||
| Enterprise Value | -4 | |||||||||
| Net Debt | 3 | |||||||||
| Equity Value | -7 | |||||||||
| Diluted Shares Outstanding, MM | 36 | |||||||||
| Equity Value Per Share | -0.19 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: HCW Biologics Inc. (HCWB) financial data pre-loaded to enhance your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing time efficiency.
Key Features
- Comprehensive HCWB Data: Pre-loaded with HCW Biologics Inc.’s historical performance metrics and future forecasts.
- Customizable Assumptions: Modify growth rates, profit margins, discount rates, tax considerations, and capital investments.
- Interactive Valuation Framework: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
- Intuitive Interface: Designed to be straightforward and accessible for both seasoned professionals and newcomers.
How It Works
- Download the Template: Gain immediate access to the Excel-based HCW Biologics Inc. (HCWB) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates HCW Biologics Inc.'s (HCWB) intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation fluctuations.
- Analyze and Decide: Utilize the findings to inform your investment or financial evaluations.
Why Choose This Calculator for HCW Biologics Inc. (HCWB)?
- Designed for Industry Experts: A sophisticated tool tailored for biopharmaceutical analysts, investors, and researchers.
- Comprehensive Data: HCW Biologics’ historical and projected financials are preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions to assess potential outcomes.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and other critical financial metrics.
- User-Friendly Interface: Step-by-step guidance makes the process straightforward and accessible.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling HCW Biologics Inc. (HCWB) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for HCW Biologics Inc. (HCWB).
- Consultants: Deliver professional valuation insights on HCW Biologics Inc. (HCWB) to clients quickly and accurately.
- Business Owners: Understand how biopharmaceutical companies like HCW Biologics Inc. (HCWB) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to HCW Biologics Inc. (HCWB).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled HCW Biologics Inc. (HCWB) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for HCW Biologics Inc. (HCWB).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.